BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32839151)

  • 1. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
    Kezlarian BE; Lin O; Dogan S
    J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
    Allard FD; Bell D; Stelow EB
    Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
    Bishop JA; Antonescu CR; Westra WH
    Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
    McHugh KE; Policarpio-Nicolas MLC
    Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.
    Dogan S; Cotzia P; Ptashkin RN; Nanjangud GJ; Xu B; Momeni Boroujeni A; Cohen MA; Pfister DG; Prasad ML; Antonescu CR; Chen Y; Gounder MM
    Hum Pathol; 2020 Oct; 104():105-116. PubMed ID: 32818509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
    Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
    Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
    Agaimy A
    Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
    Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
    Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
    Allison DB; Bishop JA; Ali SZ
    Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
    Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
    Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
    Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
    Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
    Trieu V; Aulet RM; Ciolino A; Rimash T
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.
    Agaimy A; Koch M; Lell M; Semrau S; Dudek W; Wachter DL; Knöll A; Iro H; Haller F; Hartmann A
    Am J Surg Pathol; 2014 Sep; 38(9):1274-81. PubMed ID: 24832165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
    Neves-Silva R; Almeida LY; Silveira HA; Colturato CBN; Duarte A; Ferrisse TM; Silva EV; Vanzolin BF; Bufalino A; Ribeiro-Silva A; León JE
    Head Neck; 2020 Mar; 42(3):374-384. PubMed ID: 31729110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1-deficient sinonasal adenocarcinoma: a rare variant of SWI/SNF-deficient malignancy often misclassified as high-grade non-intestinal-type sinonasal adenocarcinoma or myoepithelial carcinoma.
    Skálová A; Taheri T; Bradová M; Vaněček T; Franchi A; Slouka D; Kostlivý T; de Rezende G; Michálek J; Klubíčková N; Ptáková N; Nemcová A; Michal M; Agaimy A; Leivo I
    Virchows Arch; 2023 Dec; ():. PubMed ID: 38085333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and pathological analysis of 2 cases of
    Chen ZW; Fang SG; Ren JQ; Qian LJ; Shi HQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):400-402. PubMed ID: 32306640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.